Table of Contents
ISRN Urology
Volume 2011 (2011), Article ID 201408, 7 pages
http://dx.doi.org/10.5402/2011/201408
Review Article

Robotic-Assisted Laparoscopic Prostatectomy for High-Risk Prostate Cancer: Technical Considerations and Review of the Literature

1Division of Urology, University of California, 200 West Arbor Drive 8897, San Diego, CA 92103-8897, USA
2Section of Urologic Oncology, Moores UCSD Cancer Center, La Jolla, CA 92093, USA
3Urology Section Veterans Affairs San Diego Medical Center, La Jolla, CA 92103, USA

Received 12 July 2011; Accepted 2 August 2011

Academic Editors: B. Delahunt, R. Goel, and T. Nishiyama

Copyright © 2011 Sean P. Stroup and Christopher J. Kane. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. C. Albertsen, J. A. Hanley, and J. Fine, “20-year outcomes following conservative management of clinically localized prostate cancer,” JAMA, vol. 293, no. 17, pp. 2095–2101, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. N. Lawrentschuk, G. Trottier, C. Kuk, and A. R. Zlotta, “Role of surgery in high-risk localized prostate cancer,” Current Oncology, vol. 17, supplement 2, pp. S25–S32, 2010. View at Google Scholar · View at Scopus
  3. J. E. Montie, “Initial therapy with radical prostatectomy for high risk localized prostate cancer,” Journal of Urology, vol. 176, no. 6, pp. S27–S29, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. C. J. Kane, J. C. Presti Jr., C. L. Amling, W. J. Aronson, M. K. Terris, and S. J. Freedland, “Changing nature of high risk patients undergoing radical prostatectomy,” Journal of Urology, vol. 177, no. 1, pp. 113–117, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. H. J. Lavery, F. Nabizada-Pace, J. R. Carlucci, J. S. Brajtbord, and D. B. Samadi, “Nerve-sparing robotic prostatectomy in preoperatively high-risk patients is safe and efficacious,” Urologic Oncology. In press. View at Publisher · View at Google Scholar · View at PubMed
  6. W. S. Ham, S. Y. Park, K. H. Rha, W. T. Kim, and Y. D. Choi, “Robotic radical prostatectomy for patients with locally advanced prostate cancer is feasible: results of a single-institution study,” Journal of Laparoendoscopic and Advanced Surgical Techniques, vol. 19, no. 3, pp. 329–332, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. S. A. Shikanov, A. Thong, O. N. Gofrit et al., “Robotic laparoscopic radical prostatectomy for biopsy gleason 8 to 10: prediction of favorable pathologic outcome with preoperative parameters,” Journal of Endourology, vol. 22, no. 7, pp. 1477–1481, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. M. R. Cooperberg, D. P. Lubeck, S. S. Mehta et al., “Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE),” Journal of Urology, vol. 170, no. 6, pp. S21–S25, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. C. R. Pound, A. W. Partin, M. A. Eisenberger, D. W. Chan, J. D. Pearson, and P. C. Walsh, “Natural history of progression after PSA elevation following radical prostatectomy,” JAMA, vol. 281, no. 17, pp. 1591–1597, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. A. V. D'Amico, J. Moul, P. R. Carroll, L. Sun, D. Lubeck, and M. H. Chen, “Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era,” Journal of Clinical Oncology, vol. 21, no. 11, pp. 2163–2172, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. M. R. Cooperberg, J. Cowan, J. M. Broering, and P. R. Carroll, “High-risk prostate cancer in the United States, 1990-2007,” World Journal of Urology, vol. 26, no. 3, pp. 211–218, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. H. van Poppel and S. Joniau, “An analysis of radical prostatectomy in advanced stage and high-grade prostate cancer,” European Urology, vol. 53, no. 2, pp. 253–259, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. J. F. Donohue, F. J. Bianco, K. Kuroiwa et al., “Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading,” Journal of Urology, vol. 176, no. 3, pp. 991–995, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. W. K. Lau, E. J. Bergstralh, M. L. Blute, J. M. Slezak, and H. Zincke, “Radical prostatectomy for pathological gleason 8 or greater prostate cancer: influence of concomitant pathological variables,” Journal of Urology, vol. 167, no. 1, pp. 117–122, 2002. View at Google Scholar · View at Scopus
  15. R. K. Berglund, J. S. Jones, J. C. Ulchaker et al., “Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis,” Urology, vol. 67, no. 6, pp. 1253–1256, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. D. E. Kang, N. J. Fitzsimons, J. C. Presti Jr. et al., “Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: results from the SEARCH database,” Urology, vol. 70, no. 2, pp. 277–282, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. A. S. Kibel and J. B. Nelson, “Adjuvant and salvage treatment options for patients with high-risk prostate cancer treated with radical prostatectomy,” Prostate Cancer and Prostatic Diseases, vol. 10, no. 2, pp. 119–126, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. N. J. Fitzsimons, J. C. Presti Jr., C. J. Kane et al., “Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score?” Journal of Urology, vol. 176, no. 6, pp. 2453–2458, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. M. R. Cooperberg, S. J. Freedland, D. J. Pasta et al., “Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy,” Cancer, vol. 107, no. 10, pp. 2384–2391, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. A. J. Stephenson and M. W. Kattan, “Nomograms for prostate cancer,” BJU International, vol. 98, no. 1, pp. 39–46, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. F. E. Lecouvet, M. Simon, B. Tombal, J. Jamart, B. C. Vande Berg, and P. Simoni, “Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa),” European Radiology, vol. 20, no. 12, pp. 2973–2982, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. F. E. Lecouvet, D. Geukens, A. Stainier et al., “Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies,” Journal of Clinical Oncology, vol. 25, no. 22, pp. 3281–3287, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. J. Q. Zhang, K. R. Loughlin, K. H. Zou, S. Haker, and C. M. Tempany, “Role of endorectal coil magnetic resonance imaging in treatment of patients with prostate cancer and in determining radical prostatectomy surgical margin status: report of a single surgeon's practice,” Urology, vol. 69, no. 6, pp. 1134–1137, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. S. Shikanov, J. Woo, H. Al-Ahmadie et al., “Extrafascial versus interfascial nerve-sparing technique for robotic-assisted laparoscopic prostatectomy: comparison of functional outcomes and positive surgical margins characteristics,” Urology, vol. 74, no. 3, pp. 611–616, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. J. T. Casey, J. J. Meeks, K. A. Greco, S. D. Wu, and R. B. Nadler, “Outcomes of locally advanced (T3 or greater) prostate cancer in men undergoing robot-assisted laparoscopic prostatectomy,” Journal of Endourology, vol. 23, no. 9, pp. 1519–1522, 2009. View at Publisher · View at Google Scholar · View at PubMed
  26. G. Jayram, G. J. Decastro, M. C. Large et al., “Robotic radical prostatectomy in patients with high-risk disease: a review of short-term outcomes from a high-volume center,” Journal of Endourology, vol. 25, no. 3, pp. 455–457, 2011. View at Publisher · View at Google Scholar · View at PubMed
  27. D. S. Yee, N. Narula, M. B. Amin, D. W. Skarecky, and T. E. Ahlering, “Robot-assisted radical prostatectomy: current evaluation of surgical margins in clinically low-, intermediate-, and high-risk prostate cancer,” Journal of Endourology, vol. 23, no. 9, pp. 1461–1465, 2009. View at Publisher · View at Google Scholar · View at PubMed
  28. K. K. Badani, S. Kaul, and M. Menon, “Evolution of robotic radical prostatectomy: assessment after 2766 procedures,” Cancer, vol. 110, no. 9, pp. 1951–1958, 2007. View at Publisher · View at Google Scholar · View at PubMed
  29. A. Feicke, M. Baumgartner, S. Talimi et al., “Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases,” European Urology, vol. 55, no. 4, pp. 876–883, 2009. View at Publisher · View at Google Scholar · View at PubMed
  30. D. S. Yee, D. J. Katz, G. Godoy et al., “Extended pelvic lymph node dissection in robotic-assisted radical prostatectomy: surgical technique and initial experience,” Urology, vol. 75, no. 5, pp. 1199–1204, 2010. View at Publisher · View at Google Scholar · View at PubMed
  31. J. Yates, G. Haleblian, B. Stein, B. Miller, J. Renzulli, and G. Pareek, “The impact of robotic surgery on pelvic lymph node dissection during radical prostatectomy for localized prostate cancer: the Brown University early robotic experience,” The Canadian Journal of Urology, vol. 16, no. 5, pp. 4842–4846, 2009. View at Google Scholar
  32. M. D. Truesdale, D. J. Lee, P. J. Cheetham, G. W. Hruby, A. T. Turk, and K. K. Badani, “Assessment of lymph node yield after pelvic lymph node dissection in men with prostate cancer: a comparison between robot-assisted radical prostatectomy and open radical prostatectomy in the modern era,” Journal of Endourology, vol. 24, no. 7, pp. 1055–1060, 2010. View at Publisher · View at Google Scholar · View at PubMed
  33. F. Atug, E. P. Castle, S. K. Srivastav, S. V. Burgess, R. Thomas, and R. Davis, “Prospective evaluation of concomitant lymphadenectomy in robot-assisted radical prostatectomy: preliminary analysis of outcomes,” Journal of Endourology, vol. 20, no. 7, pp. 514–518, 2006. View at Publisher · View at Google Scholar · View at PubMed
  34. A. J. Polcari, C. M. Hugen, G. Sivarajan et al., “Comparison of open and robot-assisted pelvic lymphadenectomy for prostate cancer,” Journal of Endourology, vol. 23, no. 8, pp. 1313–1317, 2009. View at Publisher · View at Google Scholar · View at PubMed
  35. K. C. Zorn, M. H. Katz, A. Bernstein et al., “Pelvic lymphadenectomy during robot-assisted radical prostatectomy: assessing nodal yield, perioperative outcomes, and complications,” Urology, vol. 74, no. 2, pp. 296–302, 2009. View at Publisher · View at Google Scholar · View at PubMed
  36. G. Fromont, H. Baumert, X. Cathelineau, F. Rozet, P. Validire, and G. Vallancien, “Intraoperative frozen section analysis during nerve sparing laparoscopic radical prostatectomy: feasibility study,” Journal of Urology, vol. 170, no. 5, pp. 1843–1846, 2003. View at Publisher · View at Google Scholar · View at PubMed
  37. K. Nakamura, A. Kasraeian, S. Anai, J. Pendleton, and C. J. Rosser, “Positive surgical margins at radical prostatectomy: importance of intra-operative bladder neck frozen sections,” International Brazilian Journal of Urology, vol. 33, no. 6, pp. 746–751, 2007. View at Google Scholar
  38. A. K. Tewari, N. D. Patel, R. A. Leung et al., “Visual cues as a surrogate for tactile feedback during robotic-assisted laparoscopic prostatectomy: posterolateral margin rates in 1340 consecutive patients,” BJU International, vol. 106, no. 4, pp. 528–536, 2010. View at Publisher · View at Google Scholar · View at PubMed
  39. J. L. Silberstein, A. J. Vickers, N. E. Power, S. W. Fine, P. T. Scardino, J. A. Eastham et al., “Reverse stage shift at a tertiary care center: escalating Risk in Men Undergoing Radical Prostatectomy,” Cancer. In press. View at Publisher · View at Google Scholar · View at PubMed
  40. J. L. Silberstein, I. H. Derweesh, and C. J. Kane, “Lymph node dissection during robot-assisted radical prostatectomy: where do we stand?” Prostate Cancer and Prostatic Diseases, vol. 12, no. 3, pp. 227–232, 2009. View at Publisher · View at Google Scholar · View at PubMed
  41. R. Ghavamian, E. J. Bergstralh, M. L. Blute, J. Slezak, and H. Zincke, “Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison,” Journal of Urology, vol. 161, no. 4, pp. 1223–1228, 1999. View at Publisher · View at Google Scholar
  42. J. Engel, P. J. Bastian, H. Baur et al., “Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer,” European Urology, vol. 57, no. 5, pp. 754–761, 2010. View at Publisher · View at Google Scholar · View at PubMed